Rankings
▼
Calendar
INMB Q2 2025 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena
INMB
INmune Bio, Inc.
$35M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$25M
Net Income
-$24M
EPS (Diluted)
$-1.05
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$38M
Total Liabilities
$9M
Stockholders' Equity
$29M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$25M
-$10M
-149.1%
Net Income
-$24M
-$10M
-151.0%
← Q1 2025
All Quarters
Q3 2025 →